Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8571 |
High Similarity |
NPD5844 |
Phase 1 |
0.8286 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8228 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8208 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8059 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8037 |
Intermediate Similarity |
NPD920 |
Approved |
0.8023 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD919 |
Approved |
0.7964 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7939 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7929 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7925 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7857 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7798 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7722 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7705 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7697 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7692 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7607 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD37 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7558 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7557 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7531 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7527 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7527 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7458 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7423 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7421 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7414 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7399 |
Intermediate Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.7399 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7394 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7378 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7312 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7306 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7293 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7284 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7256 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7256 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7247 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7246 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7244 |
Intermediate Similarity |
NPD3972 |
Approved |
0.724 |
Intermediate Similarity |
NPD6782 |
Approved |
0.724 |
Intermediate Similarity |
NPD6781 |
Approved |
0.724 |
Intermediate Similarity |
NPD6777 |
Approved |
0.724 |
Intermediate Similarity |
NPD6779 |
Approved |
0.724 |
Intermediate Similarity |
NPD6778 |
Approved |
0.724 |
Intermediate Similarity |
NPD6780 |
Approved |
0.724 |
Intermediate Similarity |
NPD6776 |
Approved |
0.724 |
Intermediate Similarity |
NPD4107 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7238 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7214 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7212 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7193 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7179 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7169 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7152 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7136 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7128 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7128 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7121 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7117 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD4482 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7099 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7097 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7085 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7085 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7081 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD3057 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7066 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7056 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7051 |
Intermediate Similarity |
NPD17 |
Approved |
0.7049
|
Intermediate Similarity |
NPD7286 |
Phase 2 |